Add BrightSurf on Google Email

Search results for “Pharmacology”

1,000+ results for "Pharmacology"

Scientists uncover action of a risk factor for Alzheimer’s disease

Researchers found that apoE4, a high-risk version of the lipoprotein, directly promotes the development of neuritic plaques in the brain by enabling amyloid-beta to form into hair-shaped fibrils. ApoE3 had less damaging effects. The study used a mouse model and showed that apoE interaction with amyloid-beta leads to neurodegeneration.

SourceWashU Medicine·JournalProceedings of the National Academy of Sciences·DateFeb 29, 2000

A protein-processing program plays a role in cell signaling

Scientists discover a new way cells can relay messages to affect gene activity through a protein-processing program that dismantles proteins into fragments acting as messengers. The study reveals a fragment of the developmental protein Notch serves as a messenger determining a cell's fate, influencing gene activity and cell behavior.

SourceWashU Medicine·JournalMolecular Cell·DateFeb 24, 2000

University of Pittsburgh-led team finds biological reason for women's increased risk of smoking-related lung cancer

A University of Pittsburgh-led research team discovered that the gene for gastrin-releasing peptide receptor is more active in women than men, leading to increased cell proliferation and lung cancer growth. Nicotine from cigarettes also stimulates this gene expression, explaining why women are at a higher risk of developing lung cancer...

SourceUniversity of Pittsburgh Medical Center·JournalJNCI Journal of the National Cancer Institute·DateJan 3, 2000

Peering at a machine that pries DNA apart

Harvard researchers have created the first atomic-resolution image of a donut-shaped enzyme that unwinds the DNA double helix for replication. The structure reveals how six individual polypeptide lobes arrange themselves to look like a ring of bread buns, providing new insights into the molecular motor's mechanism.

SourceHarvard Medical School·JournalCell·DateOct 15, 1999

Jefferson scientists show drug is effective against a Hepatitis C Virus model in the laboratory

Researchers at Thomas Jefferson University and Oxford University have found a promising drug against the hepatitis C virus (HCV), called N-nonyl-DNJ, which inhibits the activity of an important cellular enzyme, glucosidase. This drug may sidestep resistant viruses, a major problem with current treatments.

SourceThomas Jefferson University·JournalProceedings of the National Academy of Sciences·DateOct 11, 1999

Alcohol researchers confirm molecular culprit of alcohol-induced liver damage

A study found that tumor necrosis factor-alpha (TNF-alpha) plays a crucial role in early liver damage caused by alcohol consumption. The researchers used gene knockout technology to show that TNF-alpha mediates the development of liver injury, leading to potential new drug therapies for conditions affecting millions of Americans.

Scientists dissect bacterial crosstalk

Researchers found a dual-purpose protein, FucR, that allows Bacteroides thetaiotaomicron to control its nutrient intake by silencing or activating genes involved in fucose metabolism. This communication mechanism may be crucial for maintaining intestinal ecosystem stability and preventing the overgrowth of harmful microbes.

SourceWashU Medicine·JournalProceedings of the National Academy of Sciences·DateAug 20, 1999